Suppr超能文献

子宫肌瘤治疗决策中共同决策的患者建议

Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions.

作者信息

Riggan Kirsten A, Stewart Elizabeth A, Balls-Berry Joyce E, Venable Sateria, Allyse Megan A

机构信息

Biomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.

Department of Obstetrics & Gynecology, Mayo Clinic, Rochester, MN, USA.

出版信息

J Patient Exp. 2021 Oct 20;8:23743735211049655. doi: 10.1177/23743735211049655. eCollection 2021.

Abstract

Uterine fibroids are noncancerous tumors associated with significant morbidity among symptomatic patients. While medical and surgical treatments have expanded, hysterectomy remains common. We interviewed women diagnosed with uterine fibroids ( = 47) to explore their experiences and recommendations for shared decision-making. A majority were non-Hispanic Black, highly educated (51.1%), and had graduate degrees (40.4%). Participants with both positive and negative provider experiences expressed a desire for a more proactive therapeutic approach, including a presentation by their provider of the spectrum of medical and surgical treatment options, and greater provider recognition of the impact of symptoms on quality of life. Women advocated for expanded shared decision-making that acknowledged their contribution to their own treatment plan and felt early screening and improved patient/provider education of uterine fibroid symptoms would facilitate greater congruence between treatment approaches and patient goals. Perceptions of insufficient input into their treatment plans frequently served as a barrier to care-seeking and treatment acceptance among women with uterine fibroid symptoms. Improved discussion of treatment options in the context of the unique symptom burden and values of the patient may facilitate greater provider trust and acceptance of uterine fibroid treatment.

摘要

子宫肌瘤是一种非癌性肿瘤,在有症状的患者中会引发严重疾病。尽管医学和手术治疗方法有所增加,但子宫切除术仍然很常见。我们采访了被诊断为子宫肌瘤的女性(n = 47),以探讨她们的经历以及对共同决策的建议。大多数人是非西班牙裔黑人,受教育程度高(51.1%),拥有研究生学位(40.4%)。有过积极和消极就医经历的参与者都表示希望采用更积极主动的治疗方法,包括医生介绍各种医学和手术治疗选择,以及医生更充分认识到症状对生活质量的影响。女性主张扩大共同决策,承认她们对自身治疗方案的贡献,并认为早期筛查以及改善患者/医生对子宫肌瘤症状的教育,将有助于使治疗方法与患者目标更加契合。对于治疗方案参与度不足的认知,常常成为有子宫肌瘤症状的女性寻求治疗和接受治疗的障碍。在考虑患者独特的症状负担和价值观的背景下,改善对治疗选择的讨论,可能会增进医生与患者之间的信任,并提高对子宫肌瘤治疗的接受度。

相似文献

1
Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions.
J Patient Exp. 2021 Oct 20;8:23743735211049655. doi: 10.1177/23743735211049655. eCollection 2021.
2
The management of uterine leiomyomas.
J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8.
3
The management of uterine leiomyomas.
J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22.
4
Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.
J Racial Ethn Health Disparities. 2022 Aug;9(4):1184-1191. doi: 10.1007/s40615-021-01059-8. Epub 2021 May 19.
6
Black Women's Psychosocial Experiences with Seeking Surgical Treatment for Uterine Fibroids: Implications for Clinical Practice.
Womens Health Issues. 2021 May-Jun;31(3):263-270. doi: 10.1016/j.whi.2021.01.001. Epub 2021 Feb 18.
7
The management of uterine fibroids in women with otherwise unexplained infertility.
J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2.
8
"I Wasn't Presented With Options": Perspectives of Black Veterans Receiving Care for Uterine Fibroids in the Veterans Health Administration.
Womens Health Issues. 2023 Nov-Dec;33(6):652-660. doi: 10.1016/j.whi.2023.07.006. Epub 2023 Sep 7.
9
Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Am J Obstet Gynecol. 2018 Jun;218(6):610.e1-610.e7. doi: 10.1016/j.ajog.2018.02.002. Epub 2018 Feb 9.
10
Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
J Womens Health (Larchmt). 2018 Nov;27(11):1359-1367. doi: 10.1089/jwh.2018.7076. Epub 2018 Sep 19.

引用本文的文献

1
Risk factors for late presentation of symptomatic uterine fibroid in urban Nigeria: A mixed method study.
Womens Health (Lond). 2025 Jan-Dec;21:17455057251367143. doi: 10.1177/17455057251367143. Epub 2025 Aug 23.
2
Linzagolix - new perspectives in the pharmacotherapeutic management of uterine fibroids and endometriosis.
Prz Menopauzalny. 2025 Jun;24(2):126-130. doi: 10.5114/pm.2025.152947. Epub 2025 Jul 28.
5
The Burden of Pain Symptoms in Individuals with Uterine Fibroids-Results from a Prospective Observational Study in the USA.
Int J Womens Health. 2024 Dec 21;16:2247-2261. doi: 10.2147/IJWH.S481790. eCollection 2024.
6
Laparoscopic myomectomy without uterine manipulator for maintaining endometrial cavity integrity.
Heliyon. 2024 Oct 18;10(20):e39550. doi: 10.1016/j.heliyon.2024.e39550. eCollection 2024 Oct 30.
7
Racial Disparities in Medical Management of Uterine Fibroids Prior to Myomectomy or Hysterectomy.
J Racial Ethn Health Disparities. 2024 Jun 17. doi: 10.1007/s40615-024-02048-3.
9
Enhancing Uterine Fibroid Care: Clinician Perspectives on Diagnosis, Disparities, and Strategies for Improving Health Care.
Womens Health Rep (New Rochelle). 2024 Mar 27;5(1):293-304. doi: 10.1089/whr.2023.0113. eCollection 2024.

本文引用的文献

1
Physician experience is associated with greater underestimation of patient pain.
Patient Educ Couns. 2020 Feb;103(2):405-409. doi: 10.1016/j.pec.2019.08.040. Epub 2019 Aug 30.
3
Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
J Womens Health (Larchmt). 2018 Nov;27(11):1359-1367. doi: 10.1089/jwh.2018.7076. Epub 2018 Sep 19.
4
Uterine Fibroids: Burden and Unmet Medical Need.
Semin Reprod Med. 2017 Nov;35(6):473-480. doi: 10.1055/s-0037-1607264. Epub 2017 Nov 3.
5
Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline.
Fertil Steril. 2017 Sep;108(3):416-425. doi: 10.1016/j.fertnstert.2017.06.034.
6
Disparities in Fibroid Incidence, Prognosis, and Management.
Obstet Gynecol Clin North Am. 2017 Mar;44(1):81-94. doi: 10.1016/j.ogc.2016.11.007.
8
Uterine fibroid management: from the present to the future.
Hum Reprod Update. 2016 Nov;22(6):665-686. doi: 10.1093/humupd/dmw023. Epub 2016 Jul 27.
9
Uterine fibroids.
Nat Rev Dis Primers. 2016 Jun 23;2:16043. doi: 10.1038/nrdp.2016.43.
10
An Altered Perception of Normal: Understanding Causes for Treatment Delay in Women with Symptomatic Uterine Fibroids.
J Womens Health (Larchmt). 2016 Aug;25(8):846-52. doi: 10.1089/jwh.2015.5531. Epub 2016 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验